Latest AI and machine learning research in other cancers for healthcare professionals.
PSMA PET/CT is increasingly used for prostate cancer staging, restaging, treatment selection, and therapy response assessment. In parallel, several interpretation frameworks have been developed to standardize reporting. PROMISE version 2 integrates the PRIMARY score for local disease, molecular imaging TNM staging, and a PSMA expression score. PSMA-RADS 2.0 supports lesion-level characterization, ...
PURPOSE: This study aimed to evaluate a deep-learning (DL)-based framework to automatically perform breast cancer (BC) metabolic staging on [¹⁸F]FDG PET/CT, and to assess agreement among DL-based, nuclear medicine (NM) physician-based, and clinical staging. METHODS: A total of 403 histologically confirmed BC patients who underwent whole-body staging [¹⁸F]FDG PET/CT were retrospectively included. A...
Pediatric glioblastoma (pGBM) is an aggressive central nervous system (CNS) tumor whose pathological progression is significantly influenced by exosom...
Artificial intelligence and deep learning have expanded dental imaging analysis by enabling automated detection, classification, localization, segment...
PURPOSE: The purpose of this study was to develop a machine learning-based algorithm based on a combination of magnetic resonance imaging (MRI) and co...
Stearoyl-CoA desaturase 1 (SCD-1), a key rate-limiting enzyme in lipid metabolism, catalyzes the conversion of saturated fatty acids to monounsaturate...
Laryngeal cancer imaging research lacks standardised public datasets to enable reproducible deep learning (DL) model development. We present Laryngeal...
BACKGROUND: Melanoma is a highly aggressive malignancy with poor clinical outcomes, and endoplasmic reticulum (ER) stress plays an important role in t...
BACKGROUND: Immunotherapy has shown limited efficacy in a substantial subset of CRC patients, yet the mechanisms underlying therapeutic resistance rem...
OBJECTIVE: Adipose tissue is a highly heterogeneous and plastic endocrine and immune organ whose characteristics have been linked to prognosis in NSCL...
BACKGROUND: Non-small cell lung cancer (NSCLC) is a leading cause of cancer-related mortality, largely due to frequent metastasis to the brain and bon...
Neoadjuvant dual HER2 blockade with trastuzumab and pertuzumab plus chemotherapy represents the current standard-of-care for HER2-positive breast canc...
BACKGROUND: Early diagnosis of sub-centimeter lung metastases is critical for timely decision-making and improved prognosis in patients with colorecta...
BACKGROUNDS: Reoperation is a key therapeutic strategy for recurrent or persistent papillary thyroid carcinoma (PTC), but its outcomes remain highly h...
T-cell receptor (TCR) cross-reactivity, whereby a single TCR recognizes multiple peptide-MHC (pMHC) ligands, is essential for immune surveillance but ...
BACKGROUND: Prognostic models for hepatocellular carcinoma (HCC) may have limited accuracy. We aimed to construct and validate a novel prognostic mode...
Efforts to create rapid, non-invasive, and reliable cancer diagnostics have increasingly focused on extracellular vesicles (EVs), nanoscale carriers o...
PURPOSE: This prospective multicenter study aimed to compare the decision-making abilities of board-certified colposcopists and two commercially avail...
OBJECTIVES: To examine screening mammograms assigned high-risk scores by two artificial intelligence (AI) models, 2 and 4 years prior to screen-detect...
Hematologic malignancies remain among the most challenging cancers to treat due to genetic heterogeneity, clonal evolution, and therapy resistance. Ex...